• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0031377454
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/18/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the stent moved on the balloon.The 90% stenosed target lesion was located in the moderately tortuous and severely calcified left anterior descending artery (lad).A us 4.00 x 32mm synergy xd drug-eluting stent was delivered with a guidezilla, however, the stent shifted on the balloon.The stent was removed, and the procedure was completed with a different device.There were no patient complications reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: synergy xd mr us 4.00 x 32mm was returned for analysis.The device was received over a guidewire and inserted through the guidezilla guide catheter.A visual and tactile examination of the exposed section of hypotube (the section not inserted through the guidezilla) did not exhibit any kinks or damages.A visual examination of the distal extrusion identified no damages.A microscopic examination of the distal extrusion and balloon identified no damage.A microscopic examination of the crimped stent identified that the proximal section of the crimped stretched was pulled distally along the balloon.As a result, the crimped stent at its proximal end was bunched.As a result of the stent damage, it was not possible to retract that the damaged stent of the crimped stent back through the guidezilla catheter.The undamaged crimped stent outer diameter was measured, and the result was within maximum crimped stent profile measurement.
 
Event or Problem Description
It was reported that the stent moved on the balloon.The 90% stenosed target lesion was located in the moderately tortuous and severely calcified left anterior descending artery (lad).A us 4.00 x 32mm synergy xd drug-eluting stent was delivered with a guidezilla, however, the stent shifted on the balloon.The stent was removed, and the procedure was completed with a different device.There were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18120783
Report Number2124215-2023-63436
Device Sequence Number6988197
Product Code NIQ
UDI-Device Identifier08714729981169
UDI-Public08714729981169
Combination Product (Y/N)Y
Initial Reporter StateWI
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/20/2025
Device Lot Number0031377454
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/19/2023
Supplement Date Received by Manufacturer12/14/2023
Initial Report FDA Received Date11/13/2023
Supplement Report FDA Received Date01/08/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/21/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-